Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...

IRVINE, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to shareholders in conjunction with its first ...

Q1 2025 Earnings Call Transcript May 13, 2025 Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Q1 2025 pharma services revenue of $2.1 million, at 62% gross marginThree of the top 10 U.S. transplant centers expected to participate in clinical trialTen globally leading transplant hospitals are ...

Intel also announced that the next-generation 14A process technology, following 18A, will enter the risk production phase around 2027. The new process is expected to bring a 15%-20% improvement in ...

We've visited hundreds of artists in the studio to document their creative process. Here are ten more things we've learned ...

Operator: Ladies and gentlemen, welcome to the Evotec SE Quarterly Statement Q1 2025 Conference Call. I am George, the Chorus ...

UC researchers created a lab-on-a-chip system to track a patient’s cortisol levels. It consists of a disposable collection ...

Tan also congratulated his opponents at West Coast-Jurong West GRC, Minister for National Development Desmond Lee and team, ...

Welcome to FibroGen first quarter 2025 earnings conference call. (Operator Instructions). Please be advised today's conference is being recorded. I would not like to end the conference over to your ...

The success of fecal transplants to combat hospital-acquired diarrhea shows how crucial gut bacteria are to our bodies.

Scientists project that by 2026 the results of clinical trials being conducted in 25 countries, including Spain, will be ...